Red blood cell glutathione and plasma sulfhydryls in chronic lung disease of the newborn.
We compared the postnatal changes (days 1-28) in red blood cell glutathione and plasma sulfhydryl content in preterm babies developing chronic lung disease (CLD, n = 13) to those in babies with respiratory distress syndrome (RDS, n = 13) and control babies (n = 21). There were no initial differences in these measurements between the three groups. However, on day 28 in CLD and RDS the red blood cell glutathione was decreased compared to the control babies (p < 0.05). In CLD, there was a significant correlation between reduced/oxidized glutathione and (i) maximal FiO2 (r = -0.69, p < 0.05) and (ii) minimal a/A ratio (r = +0.73, p < 0.005). On day 28, although the plasma sulfhydryl level did not differ between the groups, the sulfhydryl/total protein ratio was decreased in CLD (p < 0.05). The late decrease in both glutathione and sulfhydryl/total protein ratio in babies with CLD suggests that oxidative stress is still ongoing at 28 days after birth and that the antioxidant capacity of their blood is still diminished at this time.
Moison
R M
RM
Department of Paediatrics, Neonatal Unit, Leiden University Hospital, The Netherlands.
Haasnoot
A A
AA
van Zoeren-Grobben
D
D
Berger
H M
HM
D000704:Analysis of Variance; D001997:Bronchopulmonary Dysplasia / Q000097:blood* / Q000175:diagnosis / Q000628:therapy; D004912:Erythrocytes / Q000378:metabolism*; D005260:Female; D005978:Glutathione / Q000097:blood* / Q000378:metabolism; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature / Q000097:blood*; D008297:Male; D010100:Oxygen / Q000627:therapeutic use; D010949:Plasma / Q000378:metabolism; D012016:Reference Values; D012121:Respiration, Artificial; D012127:Respiratory Distress Syndrome, Newborn / Q000097:blood* / Q000175:diagnosis / Q000628:therapy; D013438:Sulfhydryl Compounds / Q000097:blood* / Q000378:metabolism
D013438:Sulfhydryl Compounds; D005978:Glutathione; D010100:Oxygen